Perfluorocarbon-based antidiabetic agents

…, TM Smith, ML McCaleb, DH Prozialeck…

Index: Kees; Smith; McCaleb; Prozialeck; Cheeseman; Christos; Patt; Steiner Journal of Medicinal Chemistry, 1992 , vol. 35, # 5 p. 944 - 953

Full Text: HTML

Citation Number: 22

Abstract

In a preliminary communication (J. Med. Chem. 1989, 32, 11-13) a series of perfluoro-N-[4- (1H-tetrazol-5yl-methy1) phenyllalkanamides (perfluoro anilides I), designed as novel analogues of ciglitazone, were reported to possess oral antidiabetic activity in two genetic animal models of non-insulin-dependent diabeh mellitus (NIDDM): obese (ob/ob) and diabetic (db/db) mice. In this report, the results from a structure-activity relationship (SAR) ...

Related Articles:

Perfluoro-N-[4-(1H-tetrazol-5-ylmethyl) phenyl] alkanamides. A new class of oral antidiabetic agents

[Kees; Cheeseman; Prozialeck; Steiner Journal of Medicinal Chemistry, 1989 , vol. 32, # 1 p. 11 - 13]

Perfluoro-N-[4-(1H-tetrazol-5-ylmethyl) phenyl] alkanamides. A new class of oral antidiabetic agents

[Kees; Cheeseman; Prozialeck; Steiner Journal of Medicinal Chemistry, 1989 , vol. 32, # 1 p. 11 - 13]

More Articles...